Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03912896 · ClinicalTrials.gov registry record · NA
Taekwondo for Children With Autism Spectrum Disorder
A NA study, sponsored by Loma Linda University.
- Completed
- Registry status
- NA
- Development phase
- 6
- Enrollment target
NCT03912896 is a NA study that has completed, run by Loma Linda University. The registered enrollment target is 6 participants.
The verdict
NCT03912896, a NA study, has completed, sponsored by Loma Linda University.
- COMPLETED
- Registry status
- NA
- Development phase
- 6 participants
- Enrollment target
Study Summary
This study uses a mixed methods design to understand the effectiveness of using taekwondo as an intervention for children with ASD and its effect on social interaction skills and everyday life. Qualitative research emphasizes that meaning can be explained and interpreted only by those who experience it. A pretest-posttest design will be used to describe what occurs after the introduction of the taekwondo intervention and understand the changes that occur after exposure. Collecting information through the lived experiences and observations from the parents will be collated with the pre and post results of the children participants' social interaction skills. Qualitative data will be collected through pre and post semi-structured interviews with the parents to understand their observations of their child before and after completing the taekwondo program. Interviews will also be conducted with the child to understand their perspectives on physical activity participation. Interview questions will also explore how the effectiveness of the program has impacted the children's engagement in daily activities. Quantitative research will be collected through pre and post results from the Autism Social Skills Profile-2 (\[ASSP\] assessment that will be completed by the parents. The ASSP-2 provides a comprehensive measure of social functioning for children and adolescents with ASD.
Interventions
- BEHAVIORAL Taekwondo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2019-06-11 |
| Est. Completion | 2020-02-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03912896
The ClinicalTrials.gov registry entry for NCT03912896 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Loma Linda University, which has 237 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Taekwondo is the first listed.
NCT03912896 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03912896 about?
NCT03912896 is a clinical study titled "Taekwondo for Children With Autism Spectrum Disorder". This study uses a mixed methods design to understand the effectiveness of using taekwondo as an intervention for children with ASD and its effect on social interaction skills and everyday life. Qualitative research emphasizes that meaning can be explained and interpreted only by those who experience...
What is the current status of trial NCT03912896?
This trial is currently completed. It is a NA study. The enrollment target is 6 participants. The study started on 2019-06-11. Estimated completion is 2020-02-10.
What interventions are being tested in trial NCT03912896?
The interventions under investigation include: Taekwondo (BEHAVIORAL).
Who is sponsoring clinical trial NCT03912896?
This trial is sponsored by Loma Linda University, which has 237 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.